Clinical Trials Logo

Upper Resp Tract Infection clinical trials

View clinical trials related to Upper Resp Tract Infection.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06149494 Recruiting - Copd Clinical Trials

RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection

Start date: November 20, 2023
Phase: Phase 2
Study type: Interventional

Vapendavir (VPV) is a drug being developed to treat human rhinovirus (RV) infection, one virus responsible for the common cold. Vapendavir prevents the virus from entering cells and making more infectious copies of itself. A study is being planned to investigate VPV in patients with chronic obstructive pulmonary disease (COPD, a lung disease making it difficult to breathe) who develop a rhinoviral infection; however, VPV has not been approved for use in treating any indication (disease) by the FDA or any other global regulatory agency. Therefore, VPV is considered investigational, and the study doctor is conducting this investigational research study. Safety will be monitored throughout the entire study.

NCT ID: NCT05577065 Recruiting - Clinical trials for Upper Respiratory Tract Infections

A Study to Assess the Effect of a Probiotic on Upper Respiratory Tract Infections in Healthy Children

KLEENEX
Start date: January 30, 2023
Phase: N/A
Study type: Interventional

This study evaluates the efficacy of a single strain probiotic on the incidence, duration and severity of upper respiratory tract infections in healthy, school-age children.